Suppr超能文献

将凋亡肽 KLAKLAKKLAKLAK 融合到翻译控制肿瘤蛋白 MIIYRDLISH 的 N 端蛋白转导结构域后,其穿膜能力。

The cell penetrating ability of the proapoptotic peptide, KLAKLAKKLAKLAK fused to the N-terminal protein transduction domain of translationally controlled tumor protein, MIIYRDLISH.

机构信息

College of Pharmacy, Center for Cell Signaling and Drug Discovery Research, Ewha Womans University, Seoul, Republic of Korea.

出版信息

Biomaterials. 2011 Aug;32(22):5262-8. doi: 10.1016/j.biomaterials.2011.03.074. Epub 2011 May 12.

Abstract

We show here, that the proapoptotic peptide, KLAKLAKKLAKLAK (KLA), which by itself does not penetrate cell membranes, can do so when fused to a protein transduction domain derived from NH(2)-terminus of translationally controlled tumor protein (TCTP-PTD, MIIYRDLISH). Once inside the cell, the conjugated KLA exerts its proapoptotic activity to inhibit tumor growth. We evaluated the cellular uptake of KLA fused to TCTP-PTD (hereafter called TCTP-KLA) and its effect on cancer cell viability. The IC(50) of TCTP-KLA was between 7 and 10 μmol/L. We also evaluated its anti-tumor activity in vivo by injecting it into xenografts of lung carcinoma in Balb/c nude mice. Tumor growth inhibition resulting from treatment with TCTP-KLA was better than that of TAT-KLA. These results suggest that TCTP-KLA can be applied to design cancer therapeutics.

摘要

我们在这里展示,本身不能穿透细胞膜的促凋亡肽 KLAKLAKKLAKLAK(KLA),当与源自翻译控制肿瘤蛋白(TCTP-PTD,MIIYRDLISH)氨基末端的蛋白转导结构域融合时,可以穿透细胞膜。一旦进入细胞内,共轭的 KLA 发挥其促凋亡活性以抑制肿瘤生长。我们评估了融合到 TCTP-PTD 的 KLA(以下简称 TCTP-KLA)的细胞摄取及其对癌细胞活力的影响。TCTP-KLA 的 IC(50)值在 7 到 10 μmol/L 之间。我们还通过将其注射到 Balb/c 裸鼠的肺癌异种移植物中,在体内评估了其抗肿瘤活性。TCTP-KLA 治疗导致的肿瘤生长抑制优于 TAT-KLA。这些结果表明,TCTP-KLA 可用于设计癌症治疗药物。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验